Cited by 897Neurological disorders and treatmentsObsessive-Compulsive Spectrum DisordersTreatment of Major Depression

Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression

Open access
Malone, Donald A., Dougherty, Darin D., Rezai, Ali R., Carpenter, Linda L., Friehs, Gerhard M., Eskandar, Emad N., Rauch, Scott L., Rasmussen, Steven A. +10 more·2009·Biological Psychiatry

Abstract

Background We investigated the use of deep brain stimulation (DBS) of the ventral capsule/ventral striatum (VC/VS) for treatment refractory depression.Methods Fifteen patients with chronic, severe, highly refractory depression received open-label DBS at three collaborating clinical sites. Electrodes were implanted bilaterally in the VC/VS region. Stimulation was titrated to therapeutic benefit and the absence of adverse effects. All patients received continuous stimulation and were followed for a minimum of 6 months to longer than 4 years. Outcome measures included the Hamilton Depression Rating Scale-24 item (HDRS), the Montgomery-Asberg Depression Rating Scale (MADRS), and the Global Assessment of Function Scale (GAF).Results Significant improvements in depressive symptoms were observed during DBS treatment. Mean HDRS scores declined from 33.1 at baseline to 17.5 at 6 months and 14.3 at last follow-up. Similar improvements were seen with the MADRS (34.8, 17.9, and 15.7, respectively) and the GAF (43.4, 55.5, and 61.8, respectively). Responder rates with the HDRS were 40% at 6 months and 53.3% at last follow-up (MADRS: 46.7% and 53.3%, respectively). Remission rates were 20% at 6 months and 40% at last follow-up with the HDRS (MADRS: 26.6% and 33.3%, respectively). The DBS was well-tolerated in this group.Conclusions Deep brain stimulation of the VC/VS offers promise for the treatment of refractory major depression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2008.08.029

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Deep brain stimulation applied via electrodes situated in the accumbens area/ventral internal capsule improves depressive symptoms in treatment-refractory depression.

    “deep brain stimulation applied via electrodes situated in the accumbens area/ventral internal capsule improves depressive symptoms in treatmentrefractory depression (Malone et al, 2009;Schlaepfer et al, 2008).”

    From Neurocircuitry of Mood Disorders (2010) · cites this paper as Malone et al, 2009

  • DBS for MDD targets the cingulate cortex or striatum (including NAc) and increases activity there and in connected anhedonia/motivation areas, plus the PFC and amygdala.

    “DBS for MDD targets the cingulate cortex or the striatum, which includes the NAc, and has been shown to enhance activity in these regions and connected areas involved in anhedonia and motivation [145, 146], as well as activity in the PFC and amygdala [139].”
  • In a multi-center study, Malone and colleagues demonstrated antidepressant effects in 15 patients at a minimum of 6-month follow-up (RS: 53.3%, RM: 40%).

    “In a multi-center study, Malone and colleagues demonstrated antidepressant effects in 15 patients at a minimum of 6-month follow-up (RS: 53.3%, RM: 40%) [57].”

    From Deep brain stimulation for depression. (2022) · cites this paper as [57]

  • In the Malone et al 2009 open-label study of 15 patients with treatment-resistant depression, ventral capsule/ventral striatum deep brain stimulation yielded a 40.0% remission rate at 6 months, measured by HDRS.

    “| | Malone et al | 2009 Open label | N = 15 | 6 | 53.3% | 40.0% | HDRS |”

    From Deep brain stimulation for depression. (2022) · cites this paper as [57]

  • In the Malone et al 2009 open-label study of 15 patients with treatment-resistant depression, ventral capsule/ventral striatum deep brain stimulation yielded a 53.3% response rate at 6 months, measured by HDRS.

    “| | Malone et al | 2009 Open label | N = 15 | 6 | 53.3% | 40.0% | HDRS |”

    From Deep brain stimulation for depression. (2022) · cites this paper as [57]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 39 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [1]Murray C Lopez AD The Global Burden of Disease 1996 Cambridge, Massachusetts Harvard University Press
  2. [26]First MB Spitzer RL Gibbon M Williams JBW Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition 1995 New York New York State Psychiatric Institute, Biometrics Research

Cited by

Sorted by citations

Authors
Malone, D. A., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., Rauch, S. L., Rasmussen, S. A., Machado, A. G., Kubu, C. S., Tyrka, A. R., Price, L. H., Stypulkowski, P. H., Giftakis, J. E., Rise, M. T., Malloy, P. F., Salloway, S. P., & Greenberg, B. D.
Affiliations
  • Cleveland Clinic (US)
  • McLean Hospital (US)
  • Butler Hospital (US)
  • Brown University (US)
  • Massachusetts General Hospital (US)
  • Medtronic (United States) (US)
Corresponding author
Malone, Donald A.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2009-02
Volume
65
Issue
4
Pages
267-275
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2014786844
Cited by
897
References
39
Citations by year
2026: 16 · 2025: 20 · 2024: 41 · 2023: 46 · 2022: 37 · 2021: 38 · 2020: 34 · 2019: 51 · 2018: 45 · 2017: 57 · 2016: 58 · 2015: 70 · 2014: 70 · 2013: 64 · 2012: 81
FWCI
35.18
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5p50mh086400-05)
  • National Institute of Mental Health (P-50-MH-086400)
  • National Eye Institute (R01EY017658)
Topics
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
deep brain stimulation, ventral capsule/ventral striatum, treatment-resistant depression, depression remission, long-term outcomes
MeSH terms
Adolescent, Adult, Chronic Disease, Cognition, Depressive Disorder, Drug Resistance, Electrodes, Implanted, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Recurrence, Treatment Outcome, Neostriatum, Deep Brain Stimulation, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review